Takuto Nosaka

13PUBLICATIONS
11CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 13, 2026
Spatial Proximity Between PD-L1(+) Tumor-Associated Macrophages and CD8(+) T Cells Influences Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma.

|Feb 27, 2026
Alpha-1B Glycoprotein Is a Novel Hepatocyte-Derived Host Factor Associated with In Vitro Inhibition of HBV Replication and Hepatocellular Carcinoma Progression.

Juan Lyu, Takuto Nosaka, Yosuke Murata

|Sep 13, 2025
Proton Beam Therapy Provides Longer Survival and Preserves Muscle Mass in Hepatocellular Carcinoma Compared to TACE+RFA.

Takuto Nosaka, Ryotaro Sugata, Yosuke Murata

|Sep 13, 2025
Clinical Significance of CD90(+) Circulating Tumor Cells as Dynamic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab and Lenvatinib.

Takuto Nosaka, Yosuke Murata, Yu Akazawa

|Jul 13, 2024
Serial Changes of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.

Yosuke Murata, Takuto Nosaka, Yu Akazawa

|May 11, 2024
Programmed Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor and Monitor of Response to Atezolizumab plus Bevacizumab Treatment in Patients with Hepatocellular Carcinoma.

Takuto Nosaka, Yosuke Murata, Yu Akazawa

Pageof 3

Frequent Collaborators

9 joint publications

Yasunari Nakamoto

5 joint publications

Tatsushi Naito

3 joint publications

Tomoko Tanaka

2 joint publications

Naofumi Mukaida